Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated May 17, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orasure Technologies Inc
| -6.72K |
$5.51 | -$37,023.71 | -22.00% | 23.84K |
May 15 - May 16
| |||||||
Mallinckrodt Plc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Orasure Technologies Inc
| 20K |
$5.25 | $105,000.00 | +189.34% | 30.56K |
May 16
| |||||||
Caladrius Biosciences, Inc.
| 65.43K |
—
|
—
| +55.83% | 182.63K |
Jan 10
| |||||||
Orasure Technologies Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Orasure Technologies Inc
| 10.56K |
$9.94 | $104,996.22 |
∞
| 10.56K |
Nov 8
| |||||||
Caladrius Biosciences, Inc.
| 37.73K |
—
|
—
| +47.48% | 117.2K |
Jan 11
| |||||||
Mallinckrodt Plc
| -21.09K |
$0.13 | -$2,741.31 | -100.00% |
0
|
Nov 6
| |||||||
Cree, Inc.
| -25.25K |
$62.65 | -$1,757,541.76 | -69.13% | 11.27K |
Nov 5
| |||||||
Caladrius Biosciences, Inc.
| 79.47K |
$1.51 | $119,999.70 |
∞
| 79.47K |
Nov 1
| |||||||
Caladrius Biosciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Cree, Inc.
| 2.65K |
—
|
—
| +7.83% | 36.52K |
Sep 1
| |||||||
Mallinckrodt Plc
| -8.73K |
$2.96 | -$25,837.84 | -29.28% | 21.09K |
May 13
| |||||||
Cree, Inc.
| 3.22K |
—
|
—
| +10.49% | 33.87K |
Sep 1
| |||||||
Mallinckrodt Plc
| 10.87K |
$15.21 | -$129,695.67 | +57.37% | 29.82K |
May 15
| |||||||
Cree Inc
| 3.57K |
—
|
—
| +13.16% | 30.65K |
Sep 1
| |||||||
Mallinckrodt Plc
| 18.95K |
—
|
—
|
∞
| 18.95K |
May 16
| |||||||
Mallinckrodt Plc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Cree Inc
| 7.03K |
—
|
—
| +35.07% | 27.09K |
Sep 1
| |||||||
Valeant Pharmaceuticals International, I...
| -6.01K |
$18.00 | -$108,216.00 | -3.65% | 158.54K | +1 |
Dec 5
| ||||||
Valeant Pharmaceuticals International, I...
| -834.00 |
$23.54 | -$19,632.36 | -0.52% | 158.54K | +1 |
Aug 2
| ||||||
Valeant Pharmaceuticals International, I...
| -6.50K |
$18.00 | -$117,090.00 | -3.93% | 158.88K | +1 |
Dec 5
| ||||||
Cree Inc
| 6.43K |
—
|
—
| +47.19% | 20.05K |
Sep 1
| |||||||
Valeant Pharmaceuticals International, I...
| 37.94K |
—
|
—
| +29.76% | 165.39K | +1 |
May 12
| ||||||
Cree Inc
| -623.00 |
$30.00 | -$18,690.00 | -4.37% | 13.63K |
Feb 16
|
Scheduled
| ||||||
Cree Inc
| 4.68K |
$26.74 | -$53,324.54 | +48.91% | 14.25K |
Sep 1 - Sep 3
|
Scheduled
| ||||||
Valeant Pharmaceuticals International, I...
| 7.5K |
—
|
—
| +6.25% | 127.45K | +1 |
Jul 20
| ||||||
Valeant Pharmaceuticals International, I...
| 112.45K |
—
|
—
| +1,499.40% | 119.95K | +1 |
May 13
| ||||||
Valeant Pharmaceuticals International, I...
| 7.5K |
$234.67 | $1,760,000.00 |
∞
| 7.5K |
May 26
| |||||||
Valeant Pharmaceuticals International, I...
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Synta Pharmaceuticals Corp
|
0
|
—
|
—
|
—
|
0
|
Mar 2
| |||||||
Cree Inc
| -71.00 |
$34.48 | -$3,164.24 | -0.74% | 9.57K |
Jan 21 - Jan 22
|
Scheduled
| ||||||
Cree Inc
| 687 |
$27.27 | $18,734.49 | +7.67% | 9.64K |
Oct 22
| |||||||
Cree Inc
| 4.24K |
—
|
—
| +90.14% | 8.95K |
Sep 2
| |||||||
Synta Pharmaceuticals Corp
| 500K |
—
|
—
|
∞
| 500K |
Sep 2
| |||||||
Synta Pharmaceuticals Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Cree Inc
| 4.24K |
—
|
—
| +90.14% | 8.95K |
Sep 2
| |||||||
Cree Inc
| 278 |
$44.81 | $12,457.18 | +6.28% | 4.71K |
Aug 13
| |||||||
Cree Inc
| 245 |
$51.01 | $12,497.45 | +5.85% | 4.43K |
Apr 23
| |||||||
Cree Inc
| 185 |
$67.30 | $12,450.50 | +4.63% | 4.18K |
Jan 22
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.